Valuation: Laboratorio Reig Jofre, S.A.

Market Cap 21Cr 23Cr 19Cr 18Cr 33Cr 2.23TCr 33Cr 233.01Cr 92Cr 1.16TCr 88Cr 86Cr 3.69TCr P/E 2026 *
12.8x
P/E 2027 * 21.3x
Enterprise Value 29Cr 33Cr 27Cr 25Cr 46Cr 3.13TCr 47Cr 327.31Cr 129.47Cr 1.64TCr 123.4Cr 120.76Cr 5.18TCr EV / Sales 2026 *
0.81x
EV / Sales 2027 * 0.73x
Free-Float
20.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.16%
1 week-2.30%
1 month-2.30%
3 months-3.41%
6 months-4.49%
Current year-0.78%
1 week 2.5
Extreme 2.5
2.62
1 month 2.5
Extreme 2.5
2.73
Current year 2.32
Extreme 2.32
2.94
1 year 2.32
Extreme 2.32
3
3 years 2.15
Extreme 2.15
3.4
5 years 2.02
Extreme 2.02
4.04
10 years 1.87
Extreme 1.87
6.4
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2006
Director of Finance/CFO - 20/12/2023
Chief Tech/Sci/R&D Officer - 01/01/2003
Director TitleAgeSince
Chairman - 31/12/2014
Director/Board Member 58 31/12/2014
Director/Board Member - 07/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/05/26 Buy 1,748 0.0021%
08/05/26 Buy 1,748 0.0021%
04/05/26 Buy 1,748 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-2.30%-14.14%+15.91% 24Cr
+0.45%+3.13%+54.96%+125.16% 1,13500Cr
+0.94%+4.93%+39.86%+78.72% 64TCr
+0.39%+1.44%+25.77%+97.48% 50TCr
+1.43%+4.31%+46.20%+67.12% 38TCr
-3.21%-2.10%+60.72%+33.22% 36TCr
-0.41%+2.64%+22.48%+49.82% 29TCr
+0.23%+3.66%+2.57%+23.69% 27TCr
+1.22%+4.63%+52.40%+64.85% 24TCr
+1.70%+3.67%+31.21%+102.15% 19TCr
Average +0.13%+1.33%+32.20%+65.81% 40.04TCr
Weighted average by Cap. +0.42%+1.63%+41.40%+83.60%

Financials

2026 *2027 *
Net sales 36Cr 41Cr 34Cr 31Cr 57Cr 3.88TCr 58Cr 406.25Cr 160.7Cr 2.03TCr 153.16Cr 149.89Cr 6.43TCr 39Cr 44Cr 36Cr 33Cr 61Cr 4.17TCr 62Cr 436.31Cr 172.59Cr 2.18TCr 164.49Cr 160.98Cr 6.91TCr
Net income 1.67Cr 1.87Cr 1.55Cr 1.4Cr 2.62Cr 177.68Cr 2.66Cr 19Cr 7.35Cr 93Cr 7.01Cr 6.86Cr 294.26Cr 95L 1.06Cr 87.89L 79.58L 1.49Cr 101.08Cr 1.51Cr 11Cr 4.18Cr 53Cr 3.99Cr 3.9Cr 167.39Cr
Net Debt 8.47Cr 9.47Cr 7.84Cr 7.1Cr 13Cr 901.19Cr 13Cr 94Cr 37Cr 471.35Cr 36Cr 35Cr 1.49TCr 7.87Cr 8.8Cr 7.28Cr 6.59Cr 12Cr 837.35Cr 13Cr 88Cr 35Cr 437.96Cr 33Cr 32Cr 1.39TCr
Projected Income Statement - Annual - Laboratorio Reig Jofre, S.A.
Logo Laboratorio Reig Jofre, S.A.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
Employees
1,512
Date Price Change Volume
26/26/26 €2.550 -1.16% 37,850
23/26/23 €2.580 0.00% 3,275
22/26/22 €2.580 -0.77% 4,786
21/26/21 €2.600 0.00% 6,053
20/26/20 €2.600 -0.38% 5,177
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Laboratorio Reig Jofre, S.A.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Laboratorio Reig Jofre, S.A.